nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—CHRM3—muscle of abdomen—Crohn's disease	0.101	0.387	CbGeAlD
Pancuronium—SLC22A2—Organic cation transport—SLC22A5—Crohn's disease	0.0632	0.0855	CbGpPWpGaD
Pancuronium—SLC22A2—Organic cation transport—SLC22A4—Crohn's disease	0.0632	0.0855	CbGpPWpGaD
Pancuronium—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.0589	0.0797	CbGpPWpGaD
Pancuronium—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.0589	0.0797	CbGpPWpGaD
Pancuronium—CHRNA1—mouth—Crohn's disease	0.0513	0.197	CbGeAlD
Pancuronium—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0429	0.058	CbGpPWpGaD
Pancuronium—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0429	0.058	CbGpPWpGaD
Pancuronium—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.04	0.054	CbGpPWpGaD
Pancuronium—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.04	0.054	CbGpPWpGaD
Pancuronium—CHRNA1—lymphoid tissue—Crohn's disease	0.023	0.0881	CbGeAlD
Pancuronium—SLC22A2—digestive system—Crohn's disease	0.0156	0.0599	CbGeAlD
Pancuronium—BCHE—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.0122	0.0165	CbGpPWpGaD
Pancuronium—CHRM3—smooth muscle tissue—Crohn's disease	0.0116	0.0444	CbGeAlD
Pancuronium—CHRNB1—lymph node—Crohn's disease	0.01	0.0384	CbGeAlD
Pancuronium—BCHE—smooth muscle tissue—Crohn's disease	0.00946	0.0363	CbGeAlD
Pancuronium—BCHE—skin of body—Crohn's disease	0.00934	0.0358	CbGeAlD
Pancuronium—CHRM3—digestive system—Crohn's disease	0.00915	0.0351	CbGeAlD
Pancuronium—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00859	0.0116	CbGpPWpGaD
Pancuronium—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00859	0.0116	CbGpPWpGaD
Pancuronium—BCHE—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.00853	0.0115	CbGpPWpGaD
Pancuronium—BCHE—mammalian vulva—Crohn's disease	0.00852	0.0327	CbGeAlD
Pancuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.008	0.0108	CbGpPWpGaD
Pancuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.008	0.0108	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—JAK2—Crohn's disease	0.00761	0.0103	CbGpPWpGaD
Pancuronium—BCHE—digestive system—Crohn's disease	0.00747	0.0286	CbGeAlD
Pancuronium—BCHE—Phospholipid metabolism—MTMR3—Crohn's disease	0.00725	0.00981	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.00589	0.00796	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—MLN—Crohn's disease	0.00562	0.00761	CbGpPWpGaD
Pancuronium—CHRNA1—ErbB2/ErbB3 signaling events—STAT3—Crohn's disease	0.00559	0.00756	CbGpPWpGaD
Pancuronium—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00535	0.00723	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00503	0.0068	CbGpPWpGaD
Pancuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00498	0.00674	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00459	0.0062	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00454	0.00614	CbGpPWpGaD
Pancuronium—BCHE—lymph node—Crohn's disease	0.00427	0.0164	CbGeAlD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00393	0.00531	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.0039	0.00528	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.0039	0.00528	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00389	0.00526	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00372	0.00504	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00369	0.00499	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00364	0.00492	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00364	0.00492	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—GPR65—Crohn's disease	0.00362	0.0049	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—SBSPON—Crohn's disease	0.00342	0.00463	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00324	0.00438	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—CCR9—Crohn's disease	0.00321	0.00435	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00301	0.00408	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—ACKR2—Crohn's disease	0.00299	0.00405	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00298	0.00404	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—ACKR2—Crohn's disease	0.00296	0.00401	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—MLN—Crohn's disease	0.00284	0.00384	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—MLN—Crohn's disease	0.00281	0.0038	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0028	0.00379	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00277	0.00375	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00275	0.00372	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00275	0.00371	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00258	0.00349	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00256	0.00347	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00256	0.00346	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00243	0.00329	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0024	0.00325	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00238	0.00321	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00233	0.00316	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00227	0.00306	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00213	0.00288	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.002	0.0027	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00198	0.00268	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00198	0.00268	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00198	0.00267	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—CCR9—Crohn's disease	0.00197	0.00266	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—CCR9—Crohn's disease	0.00195	0.00263	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00187	0.00253	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00185	0.0025	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00185	0.0025	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—GPR65—Crohn's disease	0.00183	0.00247	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00182	0.00246	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	0.00181	0.00245	CbGpPWpGaD
Pancuronium—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00176	0.00238	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00174	0.00236	CbGpPWpGaD
Pancuronium—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00174	0.00235	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00171	0.00231	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.0017	0.0023	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00169	0.00229	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00167	0.00227	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—MLN—Crohn's disease	0.0016	0.00217	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	0.00159	0.00215	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—ACKR2—Crohn's disease	0.00154	0.00208	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	0.00152	0.00206	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00151	0.00204	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00149	0.00202	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MLN—Crohn's disease	0.00146	0.00197	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MLN—Crohn's disease	0.00144	0.00195	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0014	0.00189	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.0013	0.00176	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0013	0.00176	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.00129	0.00174	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00123	0.00167	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PLA2G4F—Crohn's disease	0.00122	0.00165	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00115	0.00156	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.00115	0.00155	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.00114	0.00154	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.00111	0.0015	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.0011	0.00149	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	0.00109	0.00148	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—MTMR3—Crohn's disease	0.00104	0.00141	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.00103	0.0014	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00102	0.00138	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	0.00102	0.00138	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.00101	0.00136	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.000999	0.00135	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000952	0.00129	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.00094	0.00127	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000938	0.00127	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000929	0.00126	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—MTMR3—Crohn's disease	0.000929	0.00126	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000914	0.00124	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000907	0.00123	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000898	0.00121	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000875	0.00118	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—MTMR3—Crohn's disease	0.000866	0.00117	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.00086	0.00116	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000855	0.00116	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000851	0.00115	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000815	0.0011	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000815	0.0011	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—FADS1—Crohn's disease	0.00081	0.0011	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—MTMR3—Crohn's disease	0.0008	0.00108	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000786	0.00106	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000779	0.00105	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GPX4—Crohn's disease	0.000759	0.00103	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000736	0.000995	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GCKR—Crohn's disease	0.000733	0.000991	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000729	0.000986	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—FADS1—Crohn's disease	0.000723	0.000979	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000687	0.00093	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000686	0.000928	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000681	0.000921	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GPX4—Crohn's disease	0.000677	0.000916	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—FADS1—Crohn's disease	0.000674	0.000912	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000668	0.000904	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000663	0.000897	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000662	0.000895	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GCKR—Crohn's disease	0.000654	0.000885	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000652	0.000881	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000648	0.000876	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000645	0.000873	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000642	0.000868	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GPX4—Crohn's disease	0.000631	0.000854	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—FADS1—Crohn's disease	0.000623	0.000843	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GCKR—Crohn's disease	0.00061	0.000825	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000596	0.000806	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.00059	0.000798	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000588	0.000796	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GPX4—Crohn's disease	0.000583	0.000789	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000583	0.000788	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GCKR—Crohn's disease	0.000563	0.000762	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000554	0.000749	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000552	0.000746	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000551	0.000745	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000549	0.000742	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000546	0.000739	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000546	0.000738	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000535	0.000724	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000534	0.000722	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000529	0.000715	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000524	0.000708	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000501	0.000678	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000496	0.000671	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000485	0.000656	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00048	0.000649	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000458	0.00062	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000445	0.000601	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.00042	0.000568	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000418	0.000565	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000416	0.000562	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000414	0.000561	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000395	0.000534	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000391	0.000529	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000387	0.000523	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	0.000384	0.000519	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000383	0.000518	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000357	0.000483	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000354	0.000478	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000351	0.000475	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000348	0.00047	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000348	0.00047	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000344	0.000466	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000313	0.000423	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.00031	0.000419	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000304	0.000411	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000301	0.000407	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000296	0.0004	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000293	0.000397	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000286	0.000387	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000284	0.000384	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.00026	0.000351	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000259	0.000351	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000257	0.000348	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000257	0.000347	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000247	0.000335	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000245	0.000331	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000237	0.000321	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000236	0.000319	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000235	0.000318	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000234	0.000316	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—Crohn's disease	0.000233	0.000315	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000224	0.000303	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000222	0.0003	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000215	0.000291	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000213	0.000288	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—Crohn's disease	0.000208	0.000282	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000207	0.000281	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000205	0.000278	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—Crohn's disease	0.000204	0.000276	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—Crohn's disease	0.000194	0.000263	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—Crohn's disease	0.000182	0.000246	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—Crohn's disease	0.000179	0.000243	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—Crohn's disease	0.00017	0.00023	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—Crohn's disease	0.000157	0.000212	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TYK2—Crohn's disease	0.000146	0.000198	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.000145	0.000196	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JAK2—Crohn's disease	0.000139	0.000189	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.000138	0.000187	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	0.000127	0.000172	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000126	0.00017	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6—Crohn's disease	0.000121	0.000164	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.00012	0.000162	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT3—Crohn's disease	0.000102	0.000138	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.000101	0.000137	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6—Crohn's disease	7.15e-05	9.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6—Crohn's disease	7.08e-05	9.57e-05	CbGpPWpGaD
